Skip to main content

Vacancy for Pharmacist in Office of CDMO

Brundaban Sanskrutik Anusthan invites application for eligible candidate to be appointed on contractual basis for the following post for Management of Urban PHC under NUHM in Key focus Areas, Bhawanipatna

Post : Pharmacist - 01 posts

National Seminar on Recent Trends in Pharmaceutical Bio-Technology: Research, Invent and Discovery

      Society of Pharmaceutical Education & Research [SPER]
Sponsored National Seminar
on

"Recent Trends in Pharmaceutical Bio-Technology: Research,

Job for D.Pharm as Pharmacist in Sahara India Pariwar - 04 Posts

In business profit earnings and overall growth of business get the highest priority and are certainly creditable, but ultimate credibility of business enterprise, particularly of larger ones is in the utilisation of profit, be it for best possible upliftment of its workforce and for espousing Social, National Development causes or for rendering services to mankind as a whole. Fulfilling the Qualitative aspect of utilisation of profit, the world's largest family ‘Sahara India Pariwar' is proud to have reached today new horizons of growth and development.

Post: Pharmacist

Walk in interview for SRF, Therapist, Pharmacist in Central Council for Research in Siddha

The Central Council for Research in Siddha (CCRS), Chennai, an Autonomous Body under the Ministry of AYUSH, Government of India, proposes to engage the services of the following personnel on contract basis. The engagement will be initially for a period of one year. The selection will be made on the basis of Written test/Walk-in-Interview to be held as per the details given below, in the Central Council for Research in Siddha, SCRI Building, Anna Government Hospital Campus, Arumbakkam, Chennai 600 106.

Faculty requirement in Masters Pharmacy Academy

Masters pharmacy  academy, Hyderabad, is India’s No. 1 GPAT/NIPER coaching centre, planning to expand its team of experts. Since its existence in 2010; it has been committed to excellence in teaching and research. It is a Pharmacy PG entrance coaching center established by the Ex-NIPERians. We are also giving coaching for all pharmacy govt. jobs like Drugs inspector, pharmacists, Govt. Analyst, etc.  Our primary mission is to promote quality and excellence in coaching for national level aptitude test and also to access career development in building pharmacy students, so that the condition will improve from average to brilliance.  We are very much happy with our previous achievements and we hope that we continue the same in future. Thanks for visiting our website & we look forward to working with you in person soon.

Post : Faculty - 05 posts

EVALUATION OF DOOR TO NEEDLE TIME AND PREDISPOSING FACTOR TO IT IN A TERTIARY CARE HOSPITAL, CHIDAMBARAM

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
ALEEM SARWAR*1, ADHIN ANTONY XAVIER1, K RAGACHANDANA1, C K DHANAPAL1, S SUDARSHAN2
Department of Pharmacy1, Annamalai University, Chidambaram, Tamil Nadu, India
Department of Medicine2, Rajah Muthiah Medical College, Annamalai University, Chidambaram, India
aleempharma30@gmail.com

ABSTRACT
OBJECTIVE

The aim of our study is to evaluate the door to needle time for ST-segment elevation myocardial infarction and to identify factors associated with a prolonged door to needle time. STEMI most commonly occurs when thrombus formation results in complete occlusion of major epicardial coronary vessels. Percutaneous coronary intervention and Thrombolytics are the two choice of treatment available for STEMI. Where door to needle time have a significant role in determining the efficacy of thrombolytics.

METHODOLOGY
This is a prospective observational study conducted at RMMCH hospital, during the period of Nov 2014 to March 2015, all patient admitted with STEMI, who were thrombolysed were included in the study. Door to needle time is measured and reason for prolongation is identified. Patients who were diagnosed as NSTEMI or unstable angina and who were diagnosed as STEMI and not thrombolysed were excluded from the study.

RESULT
100 patients were included in the study. Which comprises of 72 males and 28 females .door to needle time of < 30 minute was achieved in 27% of study population as per ACC/AHA guidelines were 73% failed to achieve. Highest number of population was observed in the age group of 61-70 which consist of 21 males and 6 females. Mean door to needle time was found to be 44 minutes. Majority of the patients were thrombolysed in between 31 – 45 minutes

CONCLUSION
less than a third of patients with STEMI received thrombolytics within the prescribed time interval of 30 minutes. Delay in decision making and lack of senior medical officers was found to be predisposing factor for the prolongation of door to needle time ,which requires special attention.

Working opportunity as Senior Application Analyst in Cleveland Clinic

Cleveland Clinic Abu Dhabi has been made aware of fraudulent employment offers being extended to candidates in the form of emails, mails, text messages, facsimiles and/or through fraudulent websites.

Post : Senior Application Analyst

Opening to work as Officer/Executive-production in Easy Reach Management Consultants | 03 Posts

Easy Reach Placement, Established  is a excellent brand equity with a premium image amongst HR community at many Indian Giants and Blue chip Multinational Conglomerates in catering manpower placement services for our valued patrons to manage their Human Assets. In the era of Hi-tech Millennium & Rapid Globalization with prevailing competition, sourcing of Right Candidate for the Right Job at Right Time at Right Cost. Easy reach is making significant Contribution in terms of meeting our Valued Clients quality manpower requirements ranging from Junior Level to Corporate Heads.

The study conducted at the UPV/EHU-University of the Basque Country describes for the first time how these receptors participate in spermatogenesisInfertility has become a major medical and social problem worldwide and many of the cases are due to male infertility. Yet the molecular mechanisms involved in spermatogenesis are only now beginning to emerge. A piece of research led by the UPV/EHU doctor Nerea Subirán has for the first time described the presence of opioids in the cells involved in the formation of spermatozoa. The work has been published in Plos One.

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA® (adalimumab) for the treatment of non-infectious intermediate, posterior and panuveitis. HUMIRA is now the first and only FDA-approved non-corticosteroid therapy available for adults with non-infectious intermediate, posterior and panuveitis. This approval marks the 10th approved indication for HUMIRA in the United States for immune-mediated diseases.